TOE1
protein-codingtarget of EGR1, exonuclease, the group of PARN exonuclease family
Gene summary
Enables poly(A)-specific ribonuclease activity and snRNA binding activity. Involved in snRNA 3'-end processing. Located in Cajal body and cytoplasm. Implicated in pontocerebellar hypoplasia type 7. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013993
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013993
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013993
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013993
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013993
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Genitourinary; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TOE1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_025077.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 6 | 41 | 3 | 51 | |
| missense | 2 | 12 | 121 | 12 | 3 | 150 |
| nonsense | 4 | 3 | 7 | |||
| start loss | 5 | 5 | ||||
| frameshift | 4 | 6 | 4 | 14 | ||
| splice donor/acceptor (+/-2bp) | 2 | 5 | 7 | |||
| Total | 10 | 24 | 141 | 53 | 6 | 234 |
Highest pathogenic variant AF is 0.00007870775
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_079353.3 | 8 | MANE Select | |
| Ensembl | ENSP00000361162.5 | 8 | MANE Select | |
| Ensembl | ENSP00000544203.1 | 8 | Standard | |
| Ensembl | ENSP00000544203.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| toe1 | Danio rerio | Structure: post-vent region Quality: curved abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
- snRNA 3'-end processing
- RNA phosphodiester bond hydrolysis, exonucleolytic
Molecular Function
- 3'-5'-exoribonuclease activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- poly(A)-specific ribonuclease activity
- protein binding
- snRNA binding
Cellular Component
- nucleoplasm
- nucleolus
- cytoplasm
- Cajal body
- nuclear body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000372090
- Coding exons
- 8
- Length
- 4306
- Individuals with no LoFs
- 125669
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 79
- Defined
- 125748
- p
- 0.000314
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.07 | 246 | 298 | 0.826 | 0.0000178 | 3349 |
| Missense (PolyPhen) | 65 | 88.526 | 0.73425 | 1122 | ||
| Synonymous | 0.119 | 111 | 113 | 0.986 | 0.00000605 | 1018 |
| Loss of Function | -0.127 | 23 | 22.4 | 1.03 | 0.00000133 | 250 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00043 | 0.00043 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00035 | 0.00034 | rare |
| South Asian | 0.00065 | 0.00065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Inhibits cell growth rate and cell cycle. Induces CDKN1A expression as well as TGF-beta expression. Mediates the inhibitory growth effect of EGR1. Involved in the maturation of snRNAs and snRNA 3'-tail processing (PubMed:28092684). {ECO:0000269|PubMed:12562764, ECO:0000269|PubMed:28092684}.;
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- LoFtool
- 0.874
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 34.71
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.853
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |